Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Express Scripts
AstraZeneca
Colorcon
Teva
Fish and Richardson
US Army
Deloitte
Moodys

Generated: June 24, 2018

DrugPatentWatch Database Preview

CLEOCIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Cleocin patents expire, and when can generic versions of Cleocin launch?

Cleocin is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. There is one patent protecting this drug.

This drug has twenty-four patent family members in twenty-two countries.

The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Summary for CLEOCIN
Drug patent expirations by year for CLEOCIN
Pharmacology for CLEOCIN
Synonyms for CLEOCIN
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochloride
[(2R,4S,5R)-6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate hydrochloride
[6-[2-chloro-1-[(1-methyl-4-propyl-pyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] hexadecanoate hydrochloride
25507-04-4
34850-73-2
35208-55-0 (Parent)
6-{2-chloro-1-[(1-methyl-4-propylpyrrolidin-2-yl)formamido]propyl}-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl hexadecanoate hydrochloride
AB2000687
AB51459
AC-8823
AC1L1OVK
AKOS015963324
AKOS030242182
AN-7626
C-23416
C34H63ClN2O6S.HCl
C34H64Cl2N2O6S
CAS-25507-04-4
CHEBI:34647
CHEMBL1200632
Cleocin Pediatric
Cleocin pediatric (TN)
CLINDALYCIN PALMITATE HYDROCHLORIDE
Clindamycin 2-palmitate hydrochloride
Clindamycin palmitate HCl
CLINDAMYCIN PALMITATE HYDROCHLORIDE
Clindamycin palmitate hydrochloride (JAN/USP)
Clindamycin Palmitate Hydrochloride [USAN:JAN]
Clindamycin palmitate hydrochloride [USAN:USP:JAN]
Clindamycinpalmitatehydrochloride
CTK8F8720
D01990
DSSTox_CID_28660
DSSTox_GSID_48734
DSSTox_RID_82930
DTXSID3048734
J-016026
L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, monohydrochloride, (2S-trans)-
L-THREO-ALPHA-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-[[(1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL]AMINO]-1-THIO-,2-HEXADECANOATE, MONOHYDROCHLORIDE, (2S-TRANS)-
LS-174102
METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-L-THREO-ALPHA-D-GALACTO-OCTOPYRANOSIDE 2-HEXADECANOATE MONOHYDROCHLORIDE
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-palmitate monohydrochloride
MolPort-003-983-293
MolPort-028-599-793
NCGC00185773-02
NSC-759141
NSC759141
O721
Pharmakon1600-01505470
s2596
SCHEMBL41416
Tox21_113175
U 25179E
U-25,179 E
UNII-VN9A8JM7M7
VN9A8JM7M7

US Patents and Regulatory Information for CLEOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CLEOCIN clindamycin hydrochloride CAPSULE;ORAL 061809-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CLEOCIN T clindamycin phosphate GEL;TOPICAL 050615-001 Jan 7, 1987 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CLEOCIN clindamycin phosphate SUPPOSITORY;VAGINAL 050767-001 Aug 13, 1999 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pharmacia And Upjohn CLEOCIN clindamycin phosphate CREAM;VAGINAL 050680-002 Mar 2, 1998 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for CLEOCIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013025,C1304992 Lithuania ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
2013 00053 Denmark ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
13/044 Ireland ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
401 Luxembourg ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Healthtrust
Chubb
US Army
Harvard Business School
Cerilliant
Express Scripts
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.